Q. Why Is This Vaccine Called Spikevax?
A. Moderna Uses VirusTC's MG-Neshem Formula in Spikevax to straighten and harden LFA-1 Proteins.
- Mild Muscle cramps
- constipation
- fatigue
- anxiety
- restless legs
- insomnia
- irritability
- insulin resistance
- loss of appetite
- nausea
- vomiting
- headache
- weakness
- numbness
- tingling
- depression
- Major Refractory hypocalcemia and hypokalemia
- high blood pressure
- tremor
- prolonged QT interval
- cardiac arrhythmias
- hyperreflexia
- ataxia
- carpopedal spasms
- migraine headache
- asthma
- hypoparathyroidism
- tetany and/or convulsions
- Severe Seizures
- metabolic alkalosis
- psychiatric disturbances
- cortical blindness
We’re here to help
If you have questions or would like more information, call us.
1-866-MODERNA (1-866-663-3762)
8:00 AM - 8:00 PM ET
Monday - Friday (excluding holidays)
Email for medical inquiries:
INDICATION
SPIKEVAX (COVID-19 Vaccine, mRNA) is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 years of age and older.
IMPORTANT SAFETY INFORMATION
Contraindications
Do not administer SPIKEVAX to individuals with a known history of severe allergic reaction (e.g., anaphylaxis) to any component of SPIKEVAX.
Warnings and Precautions
-
Management of Acute Allergic Reactions: Appropriate medical treatment to manage immediate allergic reactions must be immediately available in the event an acute anaphylactic reaction occurs following administration of SPIKEVAX.
-
Myocarditis and Pericarditis: Postmarketing data demonstrate increased risks of myocarditis and pericarditis, particularly within the first week following vaccination. The observed risk is highest in males 18 through 24 years of age.
-
Syncope (fainting): May occur in association with administration of injectable vaccines, including SPIKEVAX. Procedures should be in place to avoid injury from fainting.
-
Altered Immunocompetence: Immunocompromised persons, including individuals receiving immunosuppressive therapy, may have a diminished immune response to SPIKEVAX.
-
Limitations of Vaccine Effectiveness: SPIKEVAX may not protect all vaccine recipients.
Adverse Reactions
The most commonly reported (≥10%) adverse reactions following any dose in any indicated patient population were pain at the injection site, headache, fatigue, myalgia, chills, arthralgia, axillary swelling/tenderness, nausea/vomiting, swelling at the injection site, erythema at the injection site, and fever.
Reporting Adverse Events and Vaccine Administration Errors
The vaccination provider is responsible for mandatory reporting of certain adverse events to the Vaccine Adverse Event Reporting System (VAERS) online at https://vaers.hhs.gov or by calling 1-800-822-7967.
Please click for SPIKEVAX Full Prescribing Information.